Form 4: SuRo Capital Director Lisa Westley Granted 7,812 Restricted Shares

Sentiment:

Insider Transaction Report


SuRo Capital Corp. Director Lisa Westley was granted 7,812 shares of common stock as restricted stock, increasing her beneficial ownership to 55,295 shares.

Summary

  • Lisa Westley, a Director of SuRo Capital Corp. (SSSS), acquired 7,812 shares of common stock on May 28, 2025.
  • These shares were granted as restricted stock under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan.
  • The shares vest in full on the earlier of May 28, 2026, or the date of the Company's annual meeting of stockholders that is closest to the first anniversary of the award date.
  • Following this transaction, Ms. Westley's total beneficial ownership of SuRo Capital Corp. common stock is 55,295 shares.

Sentiment

Score: 7

Explanation: The grant of restricted shares to a director is a positive sign of alignment between management and shareholder interests, though it's a routine compensation event rather than a major strategic announcement.

Positives

  • The grant of restricted shares aligns the director's interests with long-term shareholder value.
  • Increases the director's direct ownership in the company.

Future Outlook

The restricted shares granted to Director Lisa Westley are set to vest on the earlier of May 28, 2026, or the date of the company's annual meeting of stockholders closest to that date, indicating a future milestone for this equity compensation.

Industry Context

This transaction is a routine insider filing (Form 4) reporting a director's equity compensation. Such grants are common practice across industries to align management and director incentives with shareholder interests, particularly in the investment management sector where long-term performance is key.

Comparison to Industry Standards

  • The grant of restricted stock to a director is a standard form of equity compensation in publicly traded companies, including those in the financial services and investment sectors like SuRo Capital Corp.
  • This practice is consistent with corporate governance best practices aimed at fostering long-term alignment between directors and shareholders.
  • Specific comparable companies or projects are not detailed in this transactional filing, but similar equity incentive plans are prevalent across the S&P 500 and other listed entities.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UtilizationThe grant was made under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, indicating ongoing use of the approved plan for director compensation.05/28/2025Reinforces alignment of director incentives with long-term company performance and shareholder value.

Related Party Transactions

  • The transaction involves a director and the company, which is a related party transaction, but it's a standard compensation grant under an approved equity incentive plan.

Stakeholder Impact

  • Shareholders: Positive impact due to increased alignment of director interests with long-term company performance.

Next Steps

  • Vesting of the restricted shares on the earlier of May 28, 2026, or the date of the annual meeting closest to that date.

Key Dates

DateDescription
05/28/2025Date of transaction: Acquisition of 7,812 shares of common stock.
05/30/2025Date Form 4 was signed by Lisa Westley.
05/28/2026Earliest vesting date for the restricted shares (first anniversary of award date).

Keywords

SuRo Capital Corp., SSSS, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, Director Compensation, Lisa Westley

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.